131 related articles for article (PubMed ID: 37977289)
1. Enhanced topical paromomycin delivery for cutaneous leishmaniasis treatment: Passive and iontophoretic approaches.
de Sá FAP; Andrade JFM; Miranda TC; Cunha-Filho M; Gelfuso GM; Lapteva M; Kalia YN; Gratieri T
Int J Pharm; 2023 Dec; 648():123617. PubMed ID: 37977289
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous biodistribution of ionizable, biolabile aciclovir prodrugs after short duration topical iontophoresis: Targeted intraepidermal drug delivery.
Chen Y; Zahui T; Alberti I; Kalia YN
Eur J Pharm Biopharm; 2016 Feb; 99():94-102. PubMed ID: 26592154
[TBL] [Abstract][Full Text] [Related]
3. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
[TBL] [Abstract][Full Text] [Related]
4. Topical iontophoretic delivery of ionizable, biolabile aciclovir prodrugs: A rational approach to improve cutaneous bioavailability.
Chen Y; Alberti I; Kalia YN
Eur J Pharm Biopharm; 2016 Feb; 99():103-13. PubMed ID: 26686649
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins.
Dubey S; Kalia YN
J Control Release; 2010 Aug; 145(3):203-9. PubMed ID: 20423719
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous iontophoretic delivery of CGP69669A, a sialyl Lewis(x) mimetic, in vitro.
Gratieri T; Wagner B; Kalaria D; Ernst B; Kalia YN
Exp Dermatol; 2012 Mar; 21(3):226-8. PubMed ID: 22379971
[TBL] [Abstract][Full Text] [Related]
7. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
[TBL] [Abstract][Full Text] [Related]
8. A combination of nonionic surfactants and iontophoresis to enhance the transdermal drug delivery of ondansetron HCl and diltiazem HCl.
Silva SM; Hu L; Sousa JJ; Pais AA; Michniak-Kohn BB
Eur J Pharm Biopharm; 2012 Apr; 80(3):663-73. PubMed ID: 22137964
[TBL] [Abstract][Full Text] [Related]
9. Transdermal delivery of methotrexate: iontophoretic delivery from hydrogels and passive delivery from microemulsions.
Alvarez-Figueroa MJ; Blanco-Méndez J
Int J Pharm; 2001 Mar; 215(1-2):57-65. PubMed ID: 11250092
[TBL] [Abstract][Full Text] [Related]
10. In vitro permeability of a model protein across ocular tissues and effect of iontophoresis on the transscleral delivery.
Tratta E; Pescina S; Padula C; Santi P; Nicoli S
Eur J Pharm Biopharm; 2014 Sep; 88(1):116-22. PubMed ID: 24816128
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the cutaneous iontophoretic delivery of rasagiline and selegiline across porcine and human skin in vitro.
Kalaria DR; Patel P; Patravale V; Kalia YN
Int J Pharm; 2012 Nov; 438(1-2):202-8. PubMed ID: 22954444
[TBL] [Abstract][Full Text] [Related]
12. The influence of positive or negative charges in the passive and iontophoretic skin penetration of porphyrins used in photodynamic therapy.
Gelfuso GM; Gratieri T; Souza JG; Thomazine JA; Lopez RF
Eur J Pharm Biopharm; 2011 Feb; 77(2):249-56. PubMed ID: 21118720
[TBL] [Abstract][Full Text] [Related]
13. In vitro transdermal iontophoretic delivery of penbutolol sulfate.
Ita KB; Banga AK
Drug Deliv; 2009 Jan; 16(1):11-4. PubMed ID: 19555303
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive targeted iontophoretic delivery of cetuximab to skin.
Lapteva M; Sallam MA; Goyon A; Guillarme D; Veuthey JL; Kalia YN
Expert Opin Drug Deliv; 2020 Apr; 17(4):589-602. PubMed ID: 32067504
[No Abstract] [Full Text] [Related]
15. Effect of permeation enhancers on the iontophoretic transport of metoprolol tartrate and the drug retention in skin.
Nair A; Vyas H; Shah J; Kumar A
Drug Deliv; 2011 Jan; 18(1):19-25. PubMed ID: 20726811
[TBL] [Abstract][Full Text] [Related]
16. Topical delivery and in vivo antileishmanial activity of paromomycin-loaded liposomes for treatment of cutaneous leishmaniasis.
Carneiro G; Santos DC; Oliveira MC; Fernandes AP; Ferreira LS; Ramaldes GA; Nunan EA; Ferreira LA
J Liposome Res; 2010 Mar; 20(1):16-23. PubMed ID: 19530897
[TBL] [Abstract][Full Text] [Related]
17. Iontophoretic transdermal delivery of haloperidol.
Alvarez-Figueroa MJ; Araya-Silva I; Díaz-Tobar C
Pharm Dev Technol; 2006; 11(3):371-5. PubMed ID: 16895847
[TBL] [Abstract][Full Text] [Related]
18. Transdermal delivery of cytochrome C--A 12.4 kDa protein--across intact skin by constant-current iontophoresis.
Cázares-Delgadillo J; Naik A; Ganem-Rondero A; Quintanar-Guerrero D; Kalia YN
Pharm Res; 2007 Jul; 24(7):1360-8. PubMed ID: 17457661
[TBL] [Abstract][Full Text] [Related]
19. Treatment of cutaneous leishmaniasis with 20% paromomycin ointment.
Stanimirović A; Stipić T; Skerlev M; Basta-Juzbasić A
J Eur Acad Dermatol Venereol; 1999 Nov; 13(3):214-7. PubMed ID: 10642059
[TBL] [Abstract][Full Text] [Related]
20. Passive and iontophoretic transdermal penetration of chlorpromazine.
Alvarez-Figueroa MJ; González-Aramundiz JV
Pharm Dev Technol; 2008; 13(4):271-5. PubMed ID: 18649217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
